3 Tech Giants Quietly Investing in Synthetic Biology (ADSK, INTC, MSFT): "Project Cyborg seeks to transform the design of living systems
Computer-aided design, or CAD, software has revolutionized how our world is built. But the seamless efficiency and accuracy won't be relegated to digital movies, buildings, engine parts, and airplanes for long. Autodesk is investing in bioCAD tools for synthetic biology applications through Project Cyborg, which is part of the company's Bio/Nano/Programmable Matter Group"
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment